Doliprane and aspartate aminotransferase increased Patient Reports February 10, 2010

Doliprane Side Effects Report #4613751-0
Doliprane side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Female patient, 24 years of age, weighting 112.4 lb, was diagnosed with renal transplant and was treated with Doliprane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, epstein-barr virus antibody positive, hepatic necrosis, nephropathy toxic, renal failure. Doliprane dosage: unknown. During the same period patient was treated with NEORAL, CELLCEPT. Patient was hospitalized. Patient recovered.